CLINICAL_TRIALS
trial_result
· 2020-09-16
Clinical Trial Update: Study of Safety of RVL-1201 in Treatment of Blepharoptosis [Phase 3]
Summary
Phase 3 trial update on safety of RVL-1201 for blepharoptosis has completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: RVL Pharmaceuticals, Inc. | Conditions: Blepharoptosis | Phase 3 | Status: COMPLETED | Results posted: 2020-09-16